1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32301
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSim, Bernice L-
dc.contributor.authorSim, Beatrice Z-
dc.contributor.authorTunbridge, Matthew-
dc.contributor.authorLiew, David F L-
dc.contributor.authorRobinson, Philip C-
dc.date2022-
dc.date.accessioned2023-03-08T01:06:54Z-
dc.date.available2023-03-08T01:06:54Z-
dc.date.issued2023-03-
dc.identifier.citationThe Journal of Rheumatology 2023en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/32301-
dc.description.abstractThe use of colchicine has been associated with varying degrees of myelosuppression. Despite expanded use in cardiovascular and inflammatory conditions, there remains clinician concern because of potential myelosuppressive side effects. A systematic review was conducted to explore the reported myelosuppressive events of colchicine.en_US
dc.language.isoeng-
dc.subjectanemiaen_US
dc.subjectcardiovascular diseasesen_US
dc.subjectcolchicineen_US
dc.subjectevidence-based medicineen_US
dc.subjectgouten_US
dc.subjectthrombocytopeniaen_US
dc.titleExamining the Characteristics of Colchicine-Induced Myelosuppression in Clinical Cases: A Systematic Review.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleThe Journal of Rheumatologyen_US
dc.identifier.affiliationB.L. Sim, BSc, MPH, St George's Hospital Medical School, London, UK.en_US
dc.identifier.affiliationThe University of Queensland Faculty of Medicine, Herston, Queensland, Australia.en_US
dc.identifier.affiliationClinical Pharmacology and Therapeuticsen_US
dc.identifier.affiliationThe University of Queensland Faculty of Medicine, School of Medicine, Royal Brisbane Hospital Herston, and Royal Brisbane and Women's Hospital, Department of Rheumatology, Herston, Queensland, Australia. philip.robinson@uq.edu.au.en_US
dc.identifier.affiliationRheumatologyen_US
dc.identifier.affiliationMedicine (University of Melbourne)en_US
dc.identifier.doi10.3899/jrheum.220524en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-0536-8715en_US
dc.identifier.orcid0000-0003-1845-4476en_US
dc.identifier.orcid0000-0001-8814-1008en_US
dc.identifier.orcid0000-0001-8451-8883en_US
dc.identifier.orcid0000-0002-3156-3418en_US
dc.identifier.pubmedid36319015-
dc.description.volume50-
dc.description.issue3-
dc.description.startpage400-
dc.description.endpage407-
dc.subject.meshtermssecondaryNeutropenia/chemically induced-
local.name.researcherLiew, David F L
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptRheumatology-
crisitem.author.deptClinical Pharmacology and Therapeutics-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

96
checked on Nov 19, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.